Status:
COMPLETED
Identification of New Prognostic Markers in Psoriatic Arthritis
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Psoriasis
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Identification of possible markers associated with the onset and / or progression of psoriatic arthritis through comparison in patients with psoriasis alone (Ps) and patients with psoriasis with joint...
Eligibility Criteria
Inclusion
- Age ≥18 years
- For Ps group:
- plaque psoriasis no previous treatment with biological drugs
- \- For PsA group: plaque psoriasis with arthropathy no previous treatment with biological drugs but in treatment as per clinical practice or, alternatively, last treatment with drug suspended by a number of days double compared to the half-life of the drug
Exclusion
- Age \<18 years
- Pregnancy
- Neoplasia in progress or previous (\<5 years)
- Other acute or chronic inflammatory diseases
- Other rheumatological diseases
- Metabolic diseases of the primitive bone
- Recent bone fractures (\<6 months)
- Anxiety, psychosis, depressive disorders
- Inability to understand the information provided by the recruiter doctor
- For Ps group:
- treatment with biological drugs
Key Trial Info
Start Date :
May 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03455166
Start Date
May 1 2015
End Date
September 1 2017
Last Update
March 6 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.